Press Releases

 
Press Releases
Date Title and Summary View
9/15/10 Vancouver, British Columbia - September 15, 2010 Aquinox Pharmaceuticals Inc., a private, venture-backed, biopharmaceutical company developing novel and targeted small molecule therapeutics for the treatment of inflammatory disease and cancer, announced today the appointment of Csaba Szabó, M.D., Ph.D., as Vice President ...
6/17/10 Vancouver, British Columbia - June 17, 2010 Aquinox Pharmaceuticals Inc., a private, venture-backed, biopharmaceutical company developing novel and targeted small molecule therapeutics for the treatment of inflammatory disease and cancer, announced today that it has secured U.S. $25 million in the close of a Series B financing...
10/11/09 Vancouver, Canada and London, UK - October 11, 2009 Aquinox Pharmaceuticals Inc., a private, venture-backed, biopharmaceutical company developing novel and targeted small molecule therapeutics for the treatment of inflammatory disease and cancer, announced today at BioPartnering Europe in London, UK, that it has selec...
7/10/08 Vancouver, British Columbia - July 10, 2008 Aquinox Pharmaceuticals is pleased to announce the addition of Dr. Daniel Levitt as an independent member of the Board of Directors. Dr. Levitt joined Cerimon Pharmaceuticals Inc. of South San Francisco as its Executive Vice President, Research and Development in January 200...
9/14/07 September 14, 2007 If you found yourself on a run-away train, would you want to switch on the brakes? Two Vancouver Coastal Health Research Institute (VCHRI) and University of British Columbia investigators have found a way to turn on the brakes of a cell, and thus halt abnormal blood-cell growth in a range of inflammatory and...
6/12/07 Vancouver, British Columbia - June 13, 2007 Aquinox Pharmaceuticals Inc., a Vancouver-based privately-held pharmaceutical company developing targeted small molecule therapeutics for the treatment of cancer and inflammatory disease, has raised US$14.5 million in a Series A venture capital financing. The financing was led by V...
Page: FirstPrevious ...
9
= add release to Briefcase